XNAS
SSNC
Market cap16bUSD
Jul 10, Last price
66.62USD
1D
2.00%
1Q
-0.79%
Jan 2017
133.32%
IPO
782.67%
Name
SS&C Technologies Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SS&C Technologies Holdings, Inc. delivers advanced software and technology-enabled services specifically tailored for the financial services and healthcare industries. The company's comprehensive technological infrastructure addresses a wide array of functions. Within financial services, this spans from front-office activities like trading and modeling, through middle-office operations such as portfolio management and reporting, to extensive back-office capabilities including accounting, performance measurement, reconciliation, clearing, and regulatory compliance. For the healthcare sector, SS&C offers solutions covering claims processing, benefit administration, care management, and sophisticated business intelligence. These integrated products and services empower professionals in both sectors to automate complex workflows and efficiently manage their critical information processing demands. Noteworthy software-enabled services encompass SS&C GlobeOp, Global Investor and Distribution Solutions, the Black Diamond Wealth Platform, and various specialized offerings for pharmacy, healthcare administration, and optimizing health outcomes. The company's software product portfolio includes tools for investment accounting and analytics, portfolio management, trading, digital process automation, banking and lending, as well as research, risk management, and training. Complementing its offerings, SS&C provides professional services, such as expert consulting and implementation assistance, along with dedicated product support. Founded in 1986 and headquartered in Windsor, Connecticut, SS&C maintains a broad international presence, serving clients across the United States, Canada, the wider Americas, the United Kingdom, Europe, the Middle East, Africa, and the Asia Pacific region, including Japan.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||